Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney Sells 27,243 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $15.43, for a total transaction of $420,359.49. Following the sale, the president now directly owns 2,276,732 shares of the company’s stock, valued at $35,129,974.76. This represents a 1.18 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total transaction of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.72, for a total transaction of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.61, for a total transaction of $408,300.00.

Alignment Healthcare Price Performance

Shares of NASDAQ ALHC opened at $15.50 on Friday. Alignment Healthcare, Inc. has a 1 year low of $4.46 and a 1 year high of $16.25. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The company’s 50-day moving average is $14.30 and its 200 day moving average is $12.36. The stock has a market capitalization of $2.97 billion, a P/E ratio of -20.13 and a beta of 1.49.

Hedge Funds Weigh In On Alignment Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the stock. R Squared Ltd purchased a new position in shares of Alignment Healthcare during the fourth quarter valued at about $55,000. RiverPark Advisors LLC purchased a new position in shares of Alignment Healthcare during the fourth quarter valued at about $106,000. Tower Research Capital LLC TRC increased its position in shares of Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock valued at $119,000 after buying an additional 6,286 shares during the period. Ballentine Partners LLC purchased a new position in shares of Alignment Healthcare during the fourth quarter valued at about $121,000. Finally, Aigen Investment Management LP purchased a new position in shares of Alignment Healthcare during the fourth quarter valued at about $129,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Analyst Upgrades and Downgrades

ALHC has been the subject of several recent research reports. William Blair reissued an “outperform” rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Barclays boosted their price target on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a research note on Friday, February 28th. Stephens reissued an “overweight” rating and issued a $17.00 price target on shares of Alignment Healthcare in a research note on Monday, February 24th. Bank of America boosted their price target on shares of Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a research note on Tuesday, March 4th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Alignment Healthcare from $14.00 to $17.00 and gave the company a “neutral” rating in a research report on Thursday, March 6th. One analyst has rated the stock with a sell rating, three have given a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Alignment Healthcare presently has an average rating of “Moderate Buy” and an average target price of $14.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.